Oregon's Attorney General sues insulin manufacturers and PBMs for $900 million, alleging price inflation and collusion, ...
Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of ...
HERCESSI(TM) becomes one of two trastuzumab biosimilars on preferred formulary placement, expanding patient access to more affordable HER2-targeted oncology therapies RALEIGH, N.C., Jan. 5, 2026 ...
Trividia Health, Inc., announced today that it’s TRUE METRIX ® Self-Monitoring Blood Glucose Systems are preferred for commercial patients on the Express Scripts National Preferred Formulary in the ...
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meters and Test Strips on the Express Scripts Commercial National Preferred Formulary Providing accurate and ...
We have recently launched a new website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription. If you already ...
The MarketWatch News Department was not involved in the creation of this content. Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest ...
Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA® ...
The court battle continues between pharmacy benefit manager Express Scripts and a class action lawsuit filed on behalf of Martella's Pharmacy customers in Somerset, Cambria and Westmoreland counties.
The law firm representing Martella's Pharmacy customers plans to file a temporary restraining order against Express Scripts for dropping the pharmacy from its provider network. Attorneys leading the ...
JOHNSTOWN, Pa. – Pharmacy Benefit Management company Express Scripts has persisted in its aim to remove Martella's Pharmacy from Highmark and UPMC-insured patient plans, even as a class-action lawsuit ...